Literature DB >> 27183383

Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.

Qian Wang, Shuai Ma, Nan Song, Xin Li, Ling Liu, Shangda Yang, Xiang Ding, Lin Shan, Xing Zhou, Dongxue Su, Yue Wang, Qi Zhang, Xinhua Liu, Na Yu, Kai Zhang, Yongfeng Shang, Zhi Yao, Lei Shi.   

Abstract

The histone demethylase PHF8 has been implicated in multiple pathological disorders, including X-linked mental retardation and tumorigenesis. However, it is not clear how the abundance and function of PHF8 are regulated. Here, we report that PHF8 physically associates with the deubiquitinase USP7. Specifically, we demonstrated that USP7 promotes deubiquitination and stabilization of PHF8, leading to the upregulation of a group of genes, including cyclin A2, that are critical for cell growth and proliferation. The USP7-encoding gene was also transcriptionally regulated by PHF8, via positive feedback. USP7 was overexpressed in breast carcinomas, and the level of expression positively correlated with expression of PHF8 and cyclin A2 and with the histological grade of breast cancer. We showed that USP7 promotes breast carcinogenesis by stabilizing PHF8 and upregulating cyclin A2 and that the interaction between USP7 and PHF8 is augmented during DNA damage. Moreover, USP7-promoted PHF8 stabilization conferred cellular resistance to genotoxic insults and was required for the recruitment of BLM and KU70, which are both essential for DNA double-strand break repair. Our study mechanistically links USP7 to epigenetic regulation and DNA repair. Moreover, these data support the pursuit of USP7 and PHF8 as potential targets for breast cancer intervention, especially in combination with chemo- or radiotherapies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27183383      PMCID: PMC4887182          DOI: 10.1172/JCI85747

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  64 in total

Review 1.  Unsafe SETs: histone lysine methyltransferases and cancer.

Authors:  Robert Schneider; Andrew J Bannister; Tony Kouzarides
Journal:  Trends Biochem Sci       Date:  2002-08       Impact factor: 13.807

2.  Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair.

Authors:  Laura Spagnolo; Angel Rivera-Calzada; Laurence H Pearl; Oscar Llorca
Journal:  Mol Cell       Date:  2006-05-19       Impact factor: 17.970

3.  A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

Authors:  Dharminder Chauhan; Ze Tian; Benjamin Nicholson; K G Suresh Kumar; Bin Zhou; Ruben Carrasco; Jeffrey L McDermott; Craig A Leach; Mariaterresa Fulcinniti; Matthew P Kodrasov; Joseph Weinstock; William D Kingsbury; Teru Hideshima; Parantu K Shah; Stephane Minvielle; Mikael Altun; Benedikt M Kessler; Robert Orlowski; Paul Richardson; Nikhil Munshi; Kenneth C Anderson
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

4.  Reduced telomere length in individuals with FMR1 premutations and full mutations.

Authors:  Edmund C Jenkins; Flora Tassone; Lingling Ye; André T Hoogeveen; W Ted Brown; Randi J Hagerman; Paul J Hagerman
Journal:  Am J Med Genet A       Date:  2012-04-09       Impact factor: 2.802

5.  USP7 cooperates with SCML2 to regulate the activity of PRC1.

Authors:  Emilio Lecona; Varun Narendra; Danny Reinberg
Journal:  Mol Cell Biol       Date:  2015-01-20       Impact factor: 4.272

6.  A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation.

Authors:  Daniela Kleine-Kohlbrecher; Jesper Christensen; Julien Vandamme; Iratxe Abarrategui; Mads Bak; Niels Tommerup; Xiaobing Shi; Or Gozani; Juri Rappsilber; Anna Elisabetta Salcini; Kristian Helin
Journal:  Mol Cell       Date:  2010-03-25       Impact factor: 17.970

7.  Elevated expression of histone demethylase PHF8 associates with adverse prognosis in patients of laryngeal and hypopharyngeal squamous cell carcinoma.

Authors:  Gangcai Zhu; Lijun Liu; Li She; Haolei Tan; Ming Wei; Changhan Chen; Zhongwu Su; Donghai Huang; Yongquan Tian; Yuanzheng Qiu; Yong Liu; Xin Zhang
Journal:  Epigenomics       Date:  2014-12-15       Impact factor: 4.778

8.  The G2/M regulator histone demethylase PHF8 is targeted for degradation by the anaphase-promoting complex containing CDC20.

Authors:  Hui-Jun Lim; Nevena V Dimova; Meng-Kwang Marcus Tan; Frederic D Sigoillot; Randall W King; Yang Shi
Journal:  Mol Cell Biol       Date:  2013-08-26       Impact factor: 4.272

9.  PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression.

Authors:  Wen Liu; Bogdan Tanasa; Oksana V Tyurina; Tian Yuan Zhou; Reto Gassmann; Wei Ting Liu; Kenneth A Ohgi; Chris Benner; Ivan Garcia-Bassets; Aneel K Aggarwal; Arshad Desai; Pieter C Dorrestein; Christopher K Glass; Michael G Rosenfeld
Journal:  Nature       Date:  2010-07-11       Impact factor: 49.962

10.  A PHF8 homolog in C. elegans promotes DNA repair via homologous recombination.

Authors:  Changrim Lee; Seokbong Hong; Min Hye Lee; Hyeon-Sook Koo
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

View more
  65 in total

Review 1.  USP7: Structure, substrate specificity, and inhibition.

Authors:  Alexandra Pozhidaeva; Irina Bezsonova
Journal:  DNA Repair (Amst)       Date:  2019-02-16

2.  Histone demethylase PHF8 promotes progression and metastasis of gastric cancer.

Authors:  Shuyan Li; Ao Sun; Xiuming Liang; Lin Ma; Li Shen; Tongyu Li; Lixin Zheng; Wenjing Shang; Wei Zhao; Jihui Jia
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

3.  Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis.

Authors:  Lin He; Xinhua Liu; Jianguo Yang; Wanjin Li; Shumeng Liu; Xujun Liu; Ziran Yang; Jie Ren; Yue Wang; Lin Shan; Chengjian Guan; Fei Pei; Liandi Lei; Yu Zhang; Xia Yi; Xiaohan Yang; Jing Liang; Rong Liu; Luyang Sun; Yongfeng Shang
Journal:  Cell Res       Date:  2018-08-22       Impact factor: 25.617

4.  Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth.

Authors:  Xue Li; Lingmei Kong; Qihong Yang; Aizhu Duan; Xiaoman Ju; Bicheng Cai; Lin Chen; Tao An; Yan Li
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

5.  Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.

Authors:  Gerald Gavory; Colin R O'Dowd; Matthew D Helm; Jakub Flasz; Elias Arkoudis; Anthony Dossang; Caroline Hughes; Eamon Cassidy; Keeva McClelland; Ewa Odrzywol; Natalie Page; Oliver Barker; Hugues Miel; Timothy Harrison
Journal:  Nat Chem Biol       Date:  2017-12-04       Impact factor: 15.040

6.  Small-molecule inhibitors of ubiquitin-specific protease 7 enhance type-I interferon antiviral efficacy by destabilizing SOCS1.

Authors:  Yukang Yuan; Ying Miao; Chenhua Zeng; Jin Liu; Xiangjie Chen; Liping Qian; Xiaofang Wang; Feng Qian; Zhengyuan Yu; Jun Wang; Guanghui Qian; Qian Fu; Haitao Lv; Hui Zheng
Journal:  Immunology       Date:  2019-12-05       Impact factor: 7.397

7.  Characterization of naturally occurring pentacyclic triterpenes as novel inhibitors of deubiquitinating protease USP7 with anticancer activity in vitro.

Authors:  Bo Jing; Meng Liu; Li Yang; Hai-Yan Cai; Jie-Bo Chen; Ze-Xi Li; Xi Kou; Yun-Zhao Wu; Dong-Jun Qin; Li Zhou; Jin Jin; Hu Lei; Han-Zhang Xu; Wei-Wei Wang; Ying-Li Wu
Journal:  Acta Pharmacol Sin       Date:  2017-11-23       Impact factor: 6.150

8.  DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.

Authors:  S Hernández-Pérez; E Cabrera; E Salido; M Lim; L Reid; S R Lakhani; K K Khanna; J M Saunus; R Freire
Journal:  Oncogene       Date:  2017-03-13       Impact factor: 9.867

9.  Dual-utility NLS drives RNF169-dependent DNA damage responses.

Authors:  Liwei An; Yiyang Jiang; Howin H W Ng; Ellen P S Man; Jie Chen; Ui-Soon Khoo; Qingguo Gong; Michael S Y Huen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-21       Impact factor: 11.205

10.  Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors.

Authors:  Colin R O'Dowd; Matthew D Helm; J S Shane Rountree; Jakub T Flasz; Elias Arkoudis; Hugues Miel; Peter R Hewitt; Linda Jordan; Oliver Barker; Caroline Hughes; Ewelina Rozycka; Eamon Cassidy; Keeva McClelland; Ewa Odrzywol; Natalie Page; Stephanie Feutren-Burton; Scarlett Dvorkin; Gerald Gavory; Timothy Harrison
Journal:  ACS Med Chem Lett       Date:  2018-02-21       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.